Insider sale
DYNE THERAPEUTICS, INC.
$2.93M
127.18K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND II, L.P. plans to sell 127.18K shares of DYNE THERAPEUTICS, INC. valued at approximately $2.93M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/6/2026ACC: 0001628280-26-047355
10% Owner
Since Dec 2022
127.18K
Shares to sell
$2.93M
Approx. market value
127.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
12/12/2022
127.18KTotal acquired127.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2022 | Private Placement Cash | 127.18K | — |
| Total | 127.18K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
127.18K
Market value
$2.93M
7/6/2026
Total
Units
127.18K
Value
$2.93M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/6/2026 | 127.18K | $2.93M | Nasdaq | Planned |
| Total | 127.18K | $2.93M | ||